Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tolvaptan in Pediatric Hyponatremia
NCT02442674Phase 3Withdrawn
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization
- Start
- Nov 2015
- Primary completion
- Jun 2017
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of tolvaptan in hyponatremia, sponsored by Otsuka Pharmaceutical Development & Commercialization. Planned start Nov 2015; status: withdrawn.
02
Drugs
tolvaptan
03
Conditions
hyponatremia
Beyond the preview
Go deeper on NCT02442674.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02442674.